Theratechnologies, Inc. (THTX): Price and Financial Metrics


Theratechnologies, Inc. (THTX): $3.52

0.02 (+0.57%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add THTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 493

in industry

THTX POWR Grades


  • Value is the dimension where THTX ranks best; there it ranks ahead of 82.93% of US stocks.
  • The strongest trend for THTX is in Stability, which has been heading down over the past 200 days.
  • THTX ranks lowest in Momentum; there it ranks in the 5th percentile.

THTX Stock Summary

  • THTX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 2.94 -- higher than merely 13.33% of US-listed equities with positive expected earnings growth.
  • THTX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 82.32% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for THTX comes in at -12.82% -- higher than that of only 17.75% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Theratechnologies Inc are PROS, CNFR, FNHC, HRTG, and HTBK.
  • THTX's SEC filings can be seen here. And to visit Theratechnologies Inc's official web site, go to www.theratech.com.

THTX Price Target

For more insight on analysts targets of THTX, see our THTX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.50 Average Broker Recommendation 1 (Strong Buy)

THTX Stock Price Chart Interactive Chart >

Price chart for THTX

THTX Price/Volume Stats

Current price $3.52 52-week high $4.25
Prev. close $3.50 52-week low $1.68
Day low $3.44 Volume 64,926
Day high $3.56 Avg. volume 502,385
50-day MA $3.49 Dividend yield N/A
200-day MA $2.70 Market Cap 330.32M

Theratechnologies, Inc. (THTX) Company Bio


Theratechnologies, Inc. is a specialty pharmaceutical company that discovers and develops therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. The Company's main product is being marketed in the United States for the reduction of excess abdominal fat n HIV-infected patients with lipodystrophy.


THTX Latest News Stream


Event/Time News Detail
Loading, please wait...

THTX Latest Social Stream


Loading social stream, please wait...

View Full THTX Social Stream

Latest THTX News From Around the Web

Below are the latest news stories about Theratechnologies Inc that investors may wish to consider to help them evaluate THTX as an investment opportunity.

Theratechnologies (THTX) Investor Presentation - Slideshow

The following slide deck was published by Theratechnologies Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | April 23, 2021

Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights

MONTREAL, April 14, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today reported business highlights and financial results for the first quarter ended February 28, 2021 (Q1 Fiscal 2021). “Theratechnologies is at a unique point in its evolution, and we have a tremendous opportunity ahead of us,” said Paul Levesque, President and Chief Executive Officer at Theratechnologies. “We are particularly pleased with the swift advancement of our Phase 1 oncology program, which has dosed its first patient, and the continued progress we have made toward advancing our Phase 3 trial in NASH. “We believe we are well-positioned for growth when ...

Yahoo | April 14, 2021

Theratechnologies, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 14, 2021/ Theratechnologies, Inc. (NASDAQ:THTX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 14, 2021 at 8:30 AM Eastern Time.

Yahoo | April 14, 2021

Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference

MONTREAL, April 12, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will present at the Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 21, 2021 at 10:30 a.m. ET. The live webcast will be available at https://wsw.com/webcast/bloomburton6/thtx/. The live and archived webcast link will also be available in the ‘News’ section of the Company’s website. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs....

Yahoo | April 12, 2021

Theratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021

MONTREAL, April 12, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies announced today that it will report its financial results for the first quarter of fiscal 2021 ended February 28, 2021 on Wednesday, April 14, 2021. A conference call will be held on April 14, 2021 at 8:30 a.m. (ET) to discuss the results. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. The conference call will be open to questions from financial analysts. Media and other interested individuals are invited to participate in the call on a “listen-only” basis. The conference call can be accessed by dialing 1-844-400-1697 (toll free) or 1-703-736...

Yahoo | April 12, 2021

Read More 'THTX' Stories Here

THTX Price Returns

1-mo -11.11%
3-mo 23.08%
6-mo 57.85%
1-year 51.72%
3-year -60.89%
5-year 125.87%
YTD 40.80%
2020 -24.24%
2019 -45.90%
2018 6.41%
2017 175.59%
2016 54.07%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9255 seconds.